Intuitive Surgical Cash & Equivalents decreased by 39.1% to $2.05B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 21.6%, from $2.62B to $2.05B. Over 5 years (FY 2020 to FY 2025), Cash & Equivalents shows an upward trend with a 15.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase signals improved liquidity and financial flexibility, while a decrease may indicate heavy capital expenditure, debt repayment, or aggressive share buybacks.
Represents the most liquid assets on the balance sheet, including physical currency and short-term investments with matu...
Large-cap technology peers often maintain high cash balances to fund rapid innovation and offset the cyclical nature of consumer electronics.
cash_and_equivalents| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.63B | $1.36B | $1.29B | $1.12B | $1.55B | $1.55B | $1.58B | $2.17B | $3.46B | $3.62B | $2.75B | $2.87B | $3.07B | $2.45B | $2.03B | $2.62B | $3.45B | $2.85B | $3.37B | $2.05B |
| QoQ Change | — | -16.5% | -5.2% | -13.4% | +38.7% | +0.2% | +1.8% | +37.0% | +59.6% | +4.8% | -24.1% | +4.3% | +7.0% | -20.2% | -17.1% | +29.1% | +31.7% | -17.3% | +18.2% | -39.1% |
| YoY Change | — | — | — | — | -4.9% | +14.1% | +22.5% | +93.7% | +122.9% | +133.1% | +73.9% | +32.4% | -11.3% | -32.5% | -26.3% | -8.7% | +12.4% | +16.5% | +66.1% | -21.6% |
We use cookies for analytics. See our Privacy and Cookie Policy.